48,830
edits
Line 126: | Line 126: | ||
**Usually -ve in [[clear cell papillary renal cell carcinoma]]. | **Usually -ve in [[clear cell papillary renal cell carcinoma]]. | ||
===CCRCC versus Xp11 translocation carcinomas=== | ===CCRCC versus Xp11.2 translocation carcinomas=== | ||
ISUP recommends:<ref name=pmid25025364/> | ISUP recommends:<ref name=pmid25025364/> | ||
*Cathepsin K -ve.<ref name=pmid21602817>{{cite journal |author=Martignoni G, Gobbo S, Camparo P, ''et al.'' |title=Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions |journal=Mod. Pathol. |volume=24 |issue=10 |pages=1313–9 |year=2011 |month=October |pmid=21602817 |doi=10.1038/modpathol.2011.93 |url=}}</ref> | *Cathepsin K -ve.<ref name=pmid21602817>{{cite journal |author=Martignoni G, Gobbo S, Camparo P, ''et al.'' |title=Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions |journal=Mod. Pathol. |volume=24 |issue=10 |pages=1313–9 |year=2011 |month=October |pmid=21602817 |doi=10.1038/modpathol.2011.93 |url=}}</ref> |
edits